Akili, Inc. announced that it has entered subscription agreement for the private placement of 16,200,000 shares at a price of $10 per share for gross proceeds of $162,000,000 on January 26, 2022. The transaction will be led by Social Capital Suvretta Holdings Corp. I for $100,000,000 and include participation of $62,000,000 is committed by certain existing directors, officers and equity holders of investment funds managed by, SCS Sponsor I LLC, Suvretta Capital Management, LLC, new and existing investors including, Apeiron Investment Group Ltd., Temasek Holdings (Private) Limited, Eddie Martucci co-founder of PureTech Health, Evidity Health Capital, JAZZ Venture Partners and Omidyar Technology Ventures.